How would you approach GLP-1/GIP agonist use for MASLD management in a patient who had a prior episode of pancreatitis?

If etiology of pancreatitis has resolved (i.e. alcohol use and patient has achieved abstinence or status post cholecystectomy for gallstone pancreatitis), then I may consider a repeat trial of GLP-1/GIP for MASH with fibrosis when there is need to address the extrahepatic risk factors (obesity, diab...